Ozempic was designed and tested for type 2 diabetes, where 1.0 mg gives good blood sugar control
Food and Drug Administration (FDA) approved semaglutide (Wegovy) for chronic weight management in adults with obesity or overweight individuals who have at least one weight-related health condition, such as hypertension, type 2 diabetes, or high cholesterol
35, 36 Dysfunctional ETC complexes may produce greater ROS and be less efficient at generating energy
The global semaglutide market is continuously expanding, owing to patent expirations, competitive positioning, regional reimbursement policies, the rising prevalence of diabetes among the youth, technological innovations, growth in pharmacotherapy, and an expansion in telemedicine platforms
So, if you have a diagnosis of type 2 diabetes, your insurance plan may cover the medication